October 2017 – Page 3 – Policy & Medicine

MedTech Europe Changes Ethical Code

Belgian Sunshine Act Decrees Issued, Providing Guidance

What California’s New Drug Transparency Law Does – And Doesn’t – Do

FDA Releases Draft Guidance for Industry: Statistical Approaches to Evaluate Analytical Similarity

CMS Announces the End of Part B Demonstration

New Research Published on Generic Competition

California Bans Prescription Discounts with Generic Equivalents

California Enacts Legislation on Reporting of Prescription Drug Costs

Webinar: Risks and Opportunities in Today’s Changing World of Continuing Medical Education